Thrombocytopenia in Relation to Tumor Size in Patients with Hepatocellular Carcinoma
Authors:
- Brian I. CarrBCBrian I. Carr
- Vito GuerraVGVito Guerra
- Petr PancoskaPPPetr Pancoska
- 18 September 2012
- journal article
- Published by S. Karger AG in Oncology
- Vol. 83 (6) , 339-345
Abstract
Background: Hepatocellular carcinoma (HCC) size at diagnosis is important in management. Without screening programs, tumor size at diagnosis is heterogeneous. Aims: To examine the clinical parameters related to tumor size. Methods: Using prospectively collected data from a 1,100-patient biopsy-proven HCC cohort presenting in the absence of screening, tumor sizes were ordered and trichotomized and the resulting terciles were compared for tumor and blood parameters. Results: The terciles were significantly different with respect to portal hypertension and thrombocytopenia, which were present in a higher percent of tercile I patients with smaller tumors. Tercile III patients with larger HCCs had the highest serum α-fetoprotein (AFP), γ-glutamyl transpeptidase (GGTP), and alkaline phosphatase (ALKP) levels and the most portal vein (PV) thrombosis. Subclassification of tercile I patients by AFP showed that patients with high serum AFP had increased numbers of tumor nodules, more PV thrombosis, higher bilirubin, ALKP, and GGTP levels, and shorter survival. Conclusions: Smaller-tumor tercile I patients had more advanced portal hypertension with thrombocytopenia than did larger-tumor patients. Tercile I patients with higher AFP levels had more frequent PV thrombosis and worse survival than those with lower AFP levels. Elevated serum GGTP and ALKP levels appear to be associated with a more aggressive HCC phenotype. These differing patterns suggest more than one HCC pathway.Keywords
This publication has 23 references indexed in Scilit:
- Small Hepatocellular Carcinoma in Chinese PatientsHepatogastroenterology, 2011
- The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional PerspectiveThe Oncologist, 2010
- Low alpha‐fetoprotein hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2010
- Network-Based Analysis of Survival for Unresectable Hepatocellular CarcinomaSeminars in Oncology, 2010
- Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: A case cohort studyJournal of Gastroenterology and Hepatology, 2008
- Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high‐risk for hepatocellular carcinomaCancer, 2006
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutationsInternational Journal of Cancer, 2004
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985